SAN FRANCISCO, April 17 /PRNewswire/ -- Burrill & Company today announced that Dr. Ganesh M. Kishore, PhD has joined the firm as Managing Director. Dr. Kishore joins the company to focus on Burrill’s activities in Malaysia, India, and the AgBio, health and wellness, industrial biotech and biofuels sectors, in addition to Burrill & Company’s general life science focus.
“We are delighted to have Kish on board. His exceptional experience in the agricultural, industrial biotech, biofuels and life sciences industry particularly at the leading edge of research will be invaluable for our Venture Group at Burrill,” said G. Steven Burrill, CEO of Burrill & Company, a San Francisco based global leader in life sciences, whose principal activities are in Venture Capital, Merchant Banking and Media.
Prior to joining Burrill, Dr. Kishore served as Vice President, Science & Technology and Chief Biotechnology Officer of DuPont. Prior to this he was the Vice President, Technology, for DuPont Agriculture & Nutrition. He joined DuPont in June of 2003 and has been focusing on R&D efforts related to biotechnology within the company. Dr. Kishore previously served as Co- President, Nutrition & Consumer Sector and Assistant Chief Scientist/Chief Biotechnologist for Monsanto Company, which he joined in 1980.
His contributions include the discovery, development and commercialization of ag-bio products, manufacturing processes for Nutrasweet(R) and the transformation of a chemical giant into a leading food and nutrition company. Dr. Kishore received a B.S.c in Physics and Chemistry, an M.S.c in Biochemistry from the University of Mysore and a Ph.D. in Biochemistry at the Indian Institute of Science and undertook Postdoctoral Training at the University of Texas at Austin.
Dr. Kishore is a member of the American Association for the Advancement of Science, the American Society of Biochemistry and Molecular Biology, the American Society of Plant Physiologists, and the Institute of Food Technology. He is a founder of the plant biotech/informatics company, Metahelix Life Sciences. Dr. Kishore also serves as the chairperson for the St. Louis RCGA’s Bioenergy group. He serves on the boards of numerous “for profit” and “not- for-profit” institutions including: the School of Nutrition and Policy, Tufts’ University, St.Louis RCGA, National Research Advisory Board of the Washington University at St. Louis. He has also served as an advisor to National Science Committees in many Asian countries and venture capital groups.
Burrill & Company
Founded in 1994, Burrill & Company has over $850 million in venture capital funds under management and has an active merchant banking and media business. The company’s 50 person scientific and business team, supported by its nearly 40-person Advisory Boards, the strategic and financial network of its limited partners, and the close relationships developed with numerous life science companies and management, provide Burrill with unparalleled access and insight.
The Burrill Life Sciences Media Group LLC, a joint venture between Burrill & Company and Nielsen Business Media, publishes a wide range of biotechnology/life science bio-intelligence reports, the Journal of Life Sciences, and is also the sponsor and facilitator of over a dozen leading industry conferences. The annual book on the “State of the Industry” -- the 21st Edition -- entitled Biotech 2007-Life Sciences: A Global Transformation, is now available. Full details may be found at: http://www.burrillandco.com/ .
Burrill & Company
CONTACT: Peter Winter, Editorial Director, of Burrill & Company,+1-415-591-5474, fax, +1-415-591-5401, pwinter@b-c.com
Web site: http://www.burrillandco.com/
